Local view for "http://purl.org/linkedpolitics/eu/plenary/2017-04-05-Speech-3-291-000"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20170405.35.3-291-000"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spoken text |
"Mr President, today, having seemingly learned from the hip replacement and breast implant scandals, the medical devices regulations have been updated. This should be welcomed. Introduced are a concentration limit for 1B carcinogenic, mutagenic and repro—toxic substances (CMRs), and also for endocrine disrupting chemicals (EDCs) in devices that include a benefit risk assessment of their presence as they are CMRs or EDCs – lots of jargon there. Such assessments would have to be updated within five years. I only wish it could have been more speedy than that. However, all changes to medical devices that increase patient safety and patient choice, without reducing their clinical effectiveness, are to be welcomed. I am 100% sure that in the post—Brexit United Kingdom these standards will be maintained in cooperation with our European Union Member State counterparts."@en1
|
lpv:unclassifiedMetadata | |
lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples